Synthetic biology is a multidisciplinary field that uses engineering techniques to modify and improve biological components like living cells. Europe excels in synthetic biology research, however, more funding and support on entrepreneurship are needed to boost opportunities for commercialisation. We’re here to fill the gap.
We see a world where synthetic biology plays a transformative role in solving some of the world’s most pressing challenges. We believe that synthetic biology has the potential to revolutionize industries, create new markets, and provide solutions to complex problems that were previously thought to be unsolvable.
Our investment company is committed to supporting the development and growth of synthetic biology companies in Europe, the UK, and Israel. Our mission is to identify and invest in companies that are developing cutting-edge synthetic biology technologies, with a focus on those that have the potential to transform industries such as healthcare, agriculture, energy, and environmental sustainability. Our portfolio of investments reflects our commitment to advancing the field of synthetic biology and creating a more sustainable and equitable world.
Backed by a Board of renowned scientific experts, our leadership team and staff have exceptional experience in science and business.
Backed by a Board of renowned scientific experts, our leadership team and staff have exceptional experience in science and business.
These top leaders guide the decisions we make.
Luxembourg | France | Belgium
Subscribe to our news to keep in touch